About this trial
Patient therapeutic education programs have been shown to be effective in many specialties, allowing "Improving biological and psychological parameters, allowing patients to improve their health knowledge, therapeutic adherence and sense of personal effectiveness." Several studies have shown that patient knowledge, adherence and satisfaction are better after attending a therapeutic education program.
This multidisciplinary program is presented and offered to all patients with chronic disease treated by subcutaneous biotherapy, followed by dermatologists, rheumatologists and gastroenterologists of the Lorient hospital.
The study aims to demonstrate the benefit of the Patient Therapeutic Education program at GHBS Lorient "living with a chronic inflammatory disease under biotherapy" on treatment adherence, as well as the positive impact on quality of life.
Eligibility criteria
Qualifiers
All major patients followed up on GHBS for chronic inflammatory disease treated with S/C biotherapy.
Patients not opposed to their participation in the research.
Less than 3 months between inclusion and start of Therapeutic Education Program.
Disqualifiers
Subcutaneous injection by another person.
Patients with cognitive impairment.
Persons of legal age who are the subject of a legal protection (safeguarding of justice, curatorship, guardianship), persons deprived of liberty.
Pregnant women.
Trial design
Treatments tested in this trial
- questionnaires